伊维菌素可以使COVID-19转变。 我们需要找出是否可行。
在非洲，
在与伊维菌素进行“批量管理”来对抗这些破坏性疾病的地方，该药可能会带来意想不到的好处：
寄生虫学家克莱尔·奈杰里·瓦玛（Claire Njeri Wamae）写道：“这可能有助于遏制COVID-19病例并使其低于预期。”他在尼日利亚与衰弱的蠕虫作斗争已有40年。
在世界的其他角落：
在澳大利亚的实验中
伊维菌素首次报道于四月，它在培养皿中促使COVID-19病毒减少了5,000倍，基本上杀死了所有颗粒。
One Bangladesh study：
found that 100 ivermectin-treated patients “tested negative and their symptoms improved within 72 hours.”
Another retrospective review of 248 patients there, found that 115 who received ivermectin
were far less likely to need oxygen or intensive care, or to die from COVID-19.
In the Dominican Republic：
a large medical system treated 1,300 COVID patients with ivermectin and azithromycin, and declared 99 percent cured.
In Egypt：
ivermectin played a “highly significant role” in protecting 203 family members of COVID patients;
just 7 percent of treated people became infected with the virus compared to nearly 60 percent who were not treated.
Such findings have led Thomas Borody, an Australian doctor famous for a cure for stomach ulcers,
to propose a COVID therapy of ivermectin, doxycycline and zinc. “It’s an easy virus to kill,” he told a TV interviewer.
https://www.trialsitenews.com/ivermectin-could-turn-covid-19-around-we-need-to-find-out-if-it-works/